Paid Clinical Trials in Texas

Texas has 5,331 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,648 clinical trials

Evaluate RLS-1496 Topical Cream for Actinic Keratosis

for Actinic Keratosis (AK)

Sites in Pflugerville +3 more locations

Sponsor: Rubedo Life Sciences, Inc.

Sex: All·Age: 18+

Code: NCT07340697·Phase 1, Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

for Low-grade Upper Tract Urothelial Carcinoma

Drug: Nadofaragene Firadenovec

Sites in Houston +8 more locations

Sponsor: Ferring Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06668493·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

for Systemic Lupus Erythematosus

Sites in San Antonio & Allen

Sponsor: Climb Bio, Inc.

Sex: All·Age: 18 - 65

Code: NCT07011043·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in San Antonio, Austin +5 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06804824·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing

for Diabete Mellitus

Sites in Houston +1 more location

Sponsor: BioXTek

Sex: All·Age: 45 - 85

Code: NCT07326553·Phase 4·Recruiting·Listed Jan 2026

Apply to this trial

A Study of CTD402 in T-ALL/LBL Patients

for Acute Lymphocytic Leukemia Refractory

Sites in Houston +7 more locations

Sponsor: Imviva Bio

Sex: All·Age: 12+

Code: NCT07070219·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Sites in Houston +6 more locations

Sponsor: Debiopharm International SA

Sex: All·Age: 18+

Code: NCT06969430·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

ARC101 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in San Antonio +2 more locations

Sponsor: Third Arc Bio

Sex: All·Age: 18+

Code: NCT06672185·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

Non-invasive Intracranial Pressure Estimation by Measurement of the Occlusion Pressure of the Isolated Periorbital Vein

for Intracranial Pressure

1 location in Houston

Sponsor: Compremium AG

Sex: All·Age: 18+

Code: NCT07222826·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

for Lung Cancer (NSCLC)

Sites in Houston +2 more locations

Sponsor: Phrontline Biopharma

Sex: All·Age: 18+

Code: NCT07181473·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

for Breast Cancer

1 location in Galveston

Sponsor: Innoblative Designs, Inc.

Sex: Female·Age: 50+

Code: NCT07206121·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

for Triple Negative Breast Cancer

Sites in Dallas +8 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT06926920·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for Prostate Cancer Castration-resistant Prostate Cancer

Sites in San Antonio, Irving +5 more locations

Sponsor: MBrace Therapeutics

Sex: All·Age: 18+

Code: NCT07145255·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Study of WAL0921 in Patients With Glomerular Kidney Diseases

for Diabetic Nephropathies

Sites in Houston, San Antonio +7 more locations

Sponsor: Walden Biosciences

Sex: All·Age: 18 - 75

Code: NCT06466135·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

for Advanced or Metastatic Solid Tumors

Sites in San Antonio +3 more locations

Sponsor: Hanmi Pharmaceutical Company Limited

Sex: All·Age: 18+

Code: NCT06234397·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for Cancer

Sites in San Antonio +5 more locations

Sponsor: Angiex, Inc.

Sex: All·Age: 18+

Code: NCT06440005·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

EDX110 Randomized Control Trial for Treatment of DFUs

for Wound Heal

Sites in McAllen +3 more locations

Sponsor: ConvaTec Inc.

Sex: All·Age: 18 - 90

Code: NCT07209358·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women

for Healthy Participants

Sites in San Antonio +1 more location

Sponsor: UCB Biopharma SRL

Sex: Female·Age: 18+·Accepts healthy volunteers

Code: NCT06961747·Phase 1·Recruiting·Listed May 2025

Apply to this trial

SNV4818 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Houston +4 more locations

Sponsor: Pikavation Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06736704·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

SMP-3124LP in Adults With Advanced Solid Tumors

for Solid Tumor

Sites in Houston +7 more locations

Sponsor: Sumitomo Pharma America, Inc.

Sex: All·Age: 18+

Code: NCT06526819·Phase 1, Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

for Systemic Sclerosis

Drug: Nemolizumab

Sites in Arlington +1 more location

Sponsor: Galderma R&D

Sex: All·Age: 18+

Code: NCT07047690·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

for Dystrophic Epidermolysis Bullosa

Sites in San Antonio +4 more locations

Sponsor: Krystal Biotech, Inc.

Sex: All·Age: 6 Months+

Code: NCT07016750·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

for Glaucoma

Sites in El Paso +2 more locations

Sponsor: Glaukos Corporation

Sex: All·Age: 18+

Code: NCT07075718·Phase 2, Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury

for Acute Kidney Injury

Sites in Houston +2 more locations

Sponsor: Hope Biosciences LLC

Sex: All·Age: 18 - 75

Code: NCT06654193·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Houston, San Antonio +1 more location

Sponsor: OBI Pharma, Inc

Sex: All·Age: 18+

Code: NCT07124117·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study of YL242 in Subjects With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Houston, San Antonio +5 more locations

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All·Age: 18+

Code: NCT07197827·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

for Leukemia, Myelomonocytic, Chronic

Drug: Pacritinib

Sites in Houston +3 more locations

Sponsor: Theradex

Sex: All·Age: 18+

Code: NCT07033598·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

for Propionic Acidemia

Sites in Houston +6 more locations

Sponsor: ModernaTX, Inc.

Sex: All·Age: 1+

Code: NCT05130437·Phase 1, Phase 2·Recruiting·Listed Nov 2021

Apply to this trial

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

for Cataract

1 location in Houston

Sponsor: SpyGlass Pharma, Inc.

Sex: All·Age: 22+

Code: NCT07218783·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)

for Cataract

1 location in San Antonio

Sponsor: SpyGlass Pharma, Inc.

Sex: All·Age: 22+

Code: NCT07218796·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

for Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma

Sites in Dallas & San Antonio

Sponsor: Auricula Biosciences Inc.

Sex: All·Age: 18+

Code: NCT07148128·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

for Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)

Sites in Galveston +3 more locations

Sponsor: Innoviva Specialty Therapeutics

Sex: All·Age: 1 Day - 18

Code: NCT06801223·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

for Movement Disorders

Sites in Dallas +3 more locations

Sponsor: InSightec

Sex: All·Age: 30 - 99

Code: NCT05539196·Recruiting·Listed Sep 2022

Apply to this trial

Strategic Targeting for Optimal Prevention of Cancer

for Early Detection of Cancer

1 location in Prosper

Sponsor: ClinLogic LLC

Sex: All·Age: 65+

Code: NCT03897374·Recruiting·Listed Apr 2019

Apply to this trial

An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

for Cancer

1 location in San Antonio

Sponsor: Shenzhen Ionova Life Sciences Co., Ltd.

Sex: All·Age: 18+

Code: NCT04443088·Phase 1·Recruiting·Listed Jun 2020

Apply to this trial

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

for Solid Tumors

Sites in Houston +2 more locations

Sponsor: Shionogi

Sex: All·Age: 18+

Code: NCT05101070·Phase 1, Phase 2·Recruiting·Listed Nov 2021

Apply to this trial

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

for Nerve Injury

Sites in Fort Worth +3 more locations

Sponsor: Epineuron Technologies Inc.

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT05721261·Recruiting·Listed Feb 2023

Apply to this trial

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

for KRAS P.G12C

Sites in Houston +6 more locations

Sponsor: D3 Bio (Wuxi) Co., Ltd

Sex: All·Age: 18+

Code: NCT05410145·Phase 1, Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

for Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Drug: Botensilimab

Sites in Houston, Dallas +4 more locations

Sponsor: Stingray Therapeutics

Sex: All·Age: 18+

Code: NCT06589440·Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

for Chronic Myelomonocytic Leukemia

Sites in Houston +6 more locations

Sponsor: Solu Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT06950034·Phase 1·Recruiting·Listed Apr 2025

Apply to this trial